On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...